Najah Sampson/LinkedIn
Mar 3, 2026, 14:04
Najah Sampson: Understanding Key Risk Factors and Symptoms of VTE
Najah Sampson, US Internal Medicine Lead at Pfizer, shared on LinkedIn:
”Blood clots: a serious health concern we don’t talk about enough
Blood clots are often overlooked—but they can have serious consequences if missed.
Increasing awareness of how common they are, along with understanding key risk factors and symptoms, can make all the difference in early recognition.
- Recognize the signs
- Know the risks
- Take action
Awareness saves lives.
Let’s keep this conversation going and empower people with the knowledge they need to act early.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 15:09Consuela A. Albright: Clinical Advocacy in Sickle Cell Disease
-
Sep 5, 2026, 15:00Brandon Buck: Human Cell-Free DNA as a Diagnostic Tool for Aging and Rare Blood Disorders
-
Sep 5, 2026, 14:57Archil Jaliashvili: What if Normal Hb and SpO₂ Still Do not Mean Adequate Tissue Oxygenation?
-
Sep 5, 2026, 14:52Evaluating Inhibitor Risk Following Factor Product Switches – Results from ATHN 2
-
Sep 5, 2026, 14:50Sandrine Oziel-Taieb: Hematological Toxicity Management During Lu-Dotatate
-
Sep 5, 2026, 14:43Nandini Pethe: How Digital Logs Help Recognize Pediatric von Willebrand Disease
-
Sep 5, 2026, 14:36Aremu David: Solving Tic-Tac-Toe in 7ms: How I Built Nine
-
Sep 5, 2026, 13:05Sheharyar Raza: Threshold-Based Transfusion in Sickle Cell Disease
-
Sep 5, 2026, 12:34Stijn Wigerinck: A Practical Roadmap for Eosinophilia and Hypereosinophilia